These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3293049)

  • 1. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.
    Senger DR; Perruzzi CA; Ali IU
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5107-11. PubMed ID: 3293049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of T24 urinary bladder carcinoma cell sublines.
    Flatow U; Rabson AB; Rabson AS
    Int J Cancer; 1987 Aug; 40(2):240-5. PubMed ID: 3301693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.
    Hurlin PJ; Maher VM; McCormick JJ
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):187-91. PubMed ID: 2643097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
    Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
    Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
    Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.
    Ledwith BJ; Manam S; Kraynak AR; Nichols WW; Bradley MO
    Mol Cell Biol; 1990 Apr; 10(4):1545-55. PubMed ID: 1690847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced modulation of human ras oncogene expression.
    Samid D; Schaff Z; Chang EH; Friedman RM
    Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
    Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
    Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the neoplastic phenotype of EBV-established B lymphocytes by the human Ha-ras oncogene.
    Nasi S; Sirinian MI; Panetta G; Marchetti A; Jucker R
    Oncogene; 1990 Jan; 5(1):117-22. PubMed ID: 2157177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
    Gildea JJ; Golden WL; Harding MA; Theodorescu D
    Genes Chromosomes Cancer; 2000 Mar; 27(3):252-63. PubMed ID: 10679914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
    Michelin S; Daya-Grosjean L; Sureau F; Saïd S; Sarasin A; Suárez HG
    Oncogene; 1993 Jul; 8(7):1983-91. PubMed ID: 8510940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of malignant phenotype of human bladder cancer cell line by c-Ha-ras, c-myc antisense oligodeoxynucleotide].
    Li M; Yu M; Jin F
    Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):7-9. PubMed ID: 9275677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.